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Background: Biosurfactants (BS) are amphiphilic compounds produced by microbes, either on the cell surface
or secreted extracellularly. BS exhibit strong antimicrobial and anti-adhesive properties, making them good
candidates for applications used to combat infections. In this study, our goal was to assess the in vitro antimicrobial,
anti-adhesive and anti-biofilm abilities of BS produced by Lactobacillus jensenii and Lactobacillus rhamnosus against
clinical Multidrug Resistant (MDR) strains of Acinetobacter baumannii, Escherichia coli, and Staphylococcus aureus
(MRSA). Cell-bound BS from both L. jensenii and L. rhamnosus were extracted and isolated. The surface activities of
crude BS samples were evaluated using an oil spreading assay. The antimicrobial, anti-adhesive and anti-biofilm
activities of both BS against the above mentioned MDR pathogens were determined.
Results: Surface activities for both BS ranged from 6.25 to 25 mg/ml with clear zones observed between 7 and
11 cm. BS of both L. jensenii and L. rhamnosus showed antimicrobial activities against A. baumannii, E. coli and
S. aureus at 25-50 mg/ml. Anti-adhesive and anti-biofilm activities were also observed for the aforementioned
pathogens between 25 and 50 mg/ml. Finally, analysis by electron microscope indicated that the BS caused
membrane damage for A. baumannii and pronounced cell wall damage in S. aureus.
Conclusion: Our results indicate that BS isolated from two Lactobacilli strains has antibacterial properties against
MDR strains of A. baumannii, E. coli and MRSA. Both BS also displayed anti-adhesive and anti-biofilm abilities against
A. baumannii, E. coli and S. aureus. Together, these capabilities may open up possibilities for BS as an alternative
therapeutic approach for the prevention and/or treatment of hospital-acquired infections.
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Biosurfactants (BS) are amphiphilic compounds produced
mostly by microbes on their cell surface, or secreted ex-
tracellularly and exhibit strong surface and emulsifying ac-
tivities. They contain both hydrophobic and hydrophilic
moieties that can reduce the surface or interfacial tension
in liquids [1]. BS are complex molecules that include
glycolipids, rhamnolipids, lipopeptides, polysaccharide-
protein complexes, phospholipids, fatty acids and neutral
lipids [2]. Unlike synthetic surfactants, BS are diverse and
biodegradable, and have the potential for highly selective,
specialized functions. Several BS exhibit anti-bacterial,* Correspondence: cparanavit@hotmail.com
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article, unless otherwise stated.anti-fungal and anti-viral activities, making them appro-
priate candidates to combat infections [3].
The list of known BS includes surfactin, the most
powerful BS known, which is produced by Bacillus sub-
tilis [4]. Other BS with antimicrobial activity include
iturin, also produced by B. subtilis [4], mannosylery-
thritol lipids from Candida antarctica [5], rhamnolipids
from Pseudomonas aeruginosa [6] and those isolated
from probiotic bacteria Streptococcus thermophilus A
and Lactococcus lactis [7-9]. Probiotic lactobacilli, which
constitute an important part of natural microbiota, are
recognized as potent interfering bacteria due to the pro-
duction of various antimicrobial agents including BS
[10]. In one study, 15 Lactobacillus strains were tested
in vitro for BS production. It was found that all releasedMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and stationary growth phases [6].
Another valuable attribute of BS is their use as anti-
adhesive/anti-biofilm agents [3,11] as shown previously
in the lack of adhesion of Enterococcus faecalis to glass
with an adsorbed BS layer from Lactobacillus acidophilus
RC14 or Lactobacillus fermentum B54 [12].
Biofilms are conglomerations of bacterial cells protec-
ted by self-synthesized extracellular polysaccharide ma-
trices (EPS). Biofilm infections are extremely challenging
to treat because antimicrobials are less effective than
planktonic cells [13,14], thus making clearance more
challenging. The presence of biofilms causes numerous
problems in the field of medicine, interfering with clin-
ical therapy of chronic and wound-related infections as
well as persistent infections of various indwelling med-
ical devices [15]. Although numerous strategies have
been established and are currently in use to control bio-
films, the pursuit for novel, natural, and effective anti-
biofilm agents still continues [16-18].
In recent years, the use of BS as alternatives to control
biofilms has been explored extensively [19-21]. BS have
been shown to modify the surface properties of bacterial
cells and reduce their adhesive properties [4]. In ad-
dition, BS produced by bacteria have been shown to
interfere with biofilm development and cell to cell com-
munication [22-24].
Studies in the past have demonstrated the ability of
probiotic bacteria L. acidophilus-derived BS to inhibit
staphylococcal biofilm development and also induce its
dispersion [25]. BS produced by probiotic lactobacilli
have been shown to reduce adhesion of pathogenic bac-
teria to glass, silicone rubber, surgical implants, and
voice prostheses [8,12,26,27]. It is believed that when BS
is applied to a substratum surface, it modifies its hyd-
rophobicity, interfering in the microbial adhesion and
desorption processes [28,29]. Consequently, prior appli-
cation of BS on catheters and other medical insertion
materials may be used as a preventive strategy to delay
the onset of pathogenic biofilm growth of MDR bac-
teria on wounds, medical insertion materials and inertTable 1 Diameter (mm) of clearing zones on the oil surface o
concentrations of crude biosurfactant
Sample PBS Surfactin
50 mg/ml 0.0 15.0 ± 1.0
25 mg/ml 0.0 15.0 ± 1.0
12.5 mg/ml 0.0 14.6 ± 0.5
6.25 mg/ml 0.0 13.0 ± 0.5
PBS was used as a negative control with a clearing zone diameter of 0.0 mm. Surfa
three experiments performed in triplicate.surfaces in the hospital environment [8,12,25-27,30].
Thus, the prevention of biofilm formation or disrup-
tion by natural lactobacilli-derived agents was tested in
these in vitro studies as a possible approach leading to
novel antimicrobials.
The aims of this study were to determine the anti-
microbial, anti-adhesive, and anti-biofilm activities of
cell-bound BS isolated from L. jensenii and L. rhamnosus




The oil spreading assay was utilized to study the surface
activities of crude BS. This assay is rapid, and is highly
sensitive to surface active compounds [31,32]. Both L.
jensenii and L. rhamnosus strains demonstrated oil dis-
placement activity in motor oil. The oil displacement ac-
tivity, as measured by the area of the clear zone on the
oil-water surface, increased with an increase in the con-
centration of BS (Table 1).
Antimicrobial assay with BS
The crude BS of both L. jensenii and L. rhamnosus were
tested against two clinical isolates of MDR A. baumannii,
E. coli and S. aureus. We found both BS to be effective in
killing all three MDR pathogens at 50 mg/ml (Table 2). L.
jensenii BS exhibited almost 100% activity against all the
strains tested (Table 2). The activity of L. rhamnosus
ranged from 96-97% against A. baumannii and 72-85%
against E. coli. For S. aureus strains UAMS-1 and MRSA
respectively, activity was between 80 and 93% respectively
(Table 2).
Impact of BS on bacterial attachment to abiotic surface
Biofilm formation is a complex process that generally in-
volves three stages: (1) primary adhesion to surfaces, (2)
accumulation of multilayered clusters of cells, and (3)
detachment. Because binding of host proteins is a major
contributor to primary adhesion, it was important to
test initial adherence to surfaces that were coated withbtained from oil spreading assay with different
Crude biosurfactant Crude biosurfactant
L. rhamnosus L. jensenii
6.8 ± 0.5 7.6 ± 0.5
6.0 ± 1.4 6.0 ± 1.7
5.3 ± 0.5 5.6 ± 1.1
4.1 ± 0.1 3.8 ± 0.2
ctin was used as a positive control. Results shown are the average of ± SD of
Table 2 Antimicrobial activity of the crude biosurfactant from L. jensenii (BSLJ) and L. rhamnosus (BSLR) against MDR
pathogens
AB5075 AB5711 EC438 EC433 MRSA S. aureus UAMS-1 KP4640
BSLJ 99.0 100.00 99.00 99.00 99.0 99.0 99.9
SD 0.01 0 0.05 0.43 0.03 0.04 0.02
BSLR 96.35 97.85 72.34 85.34 93.27 80.54 91.6
SD 2.96 2.16 2.36 6.21 3.15 7.11 1.96
Results are from 3 independent preparations of BS. (AB = A. baumannii; EC = E. coli; MRSA =methicillin resistant S. aureus, KP = Klebsiella pneumoniae and
SD = Standard deviation). Biosurfactants were tested at 50 mg/ml concentration. Numbers are represented and percent reduction in cell numbers when treated
with BS.
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stage at which BS disrupts biofilm formation. Using an
adherence assay, the ability of two BS to inhibit the cell
attachment in the presence of host proteins was mea-
sured by coating the plates with human plasma. After
various concentrations of BS ranging from 25-50 mg/ml
were tested, it was found that the two BS significantly
impaired the attachment of A. baumannii and E. coli at
50 mg/ml (Figure 1). S. aureus adherence to abiotic sur-
faces was disrupted at concentrations between 25 and
50 mg/ml (Figure 1).Impact of BS on biofilm development
Next, it was determined if the static biofilm assay could
show whether both BS possessed anti-biofilm activity
against A. baumannii, E. coli and S. aureus. The BS pro-
duced by both L. jensenii and L. rhamnosus significantly
reduced biofilm development by A. baumannii and E.
coli at 50 mg/ml (Figure 2). Furthermore, the two BSFigure 1 The ability of biosurfactant from L. jensenii (BSLJ)
and L. rhamnosus (BSLR) to reduce initial adherence of
A. baumannii, E. coli and S. aureus is indicated. BS was used at
50 mg/ml for A. baumannii, E. coli and at 25 mg/ml for S. aureus.
Treated cells were statistically different from controls. The results
represent the means plus SEM. Student’s paired t test was used to
determine the statistical significance of the treated versus untreated
conditions (*, P < 0.05).significantly inhibited S. aureus biofilms at both concen-
trations of 25 mg/ml respectively (Figure 2).
Dispersion of preformed biofilms by BS
In the experiments thus far, the BS were added concur-
rently with inoculation of bacteria. To determine if these
compounds dispersed preformed biofilms, A. baumannii
and E. coli biofilms were developed on MBEC pegs, and
then exposed to varying concentrations of BS in fresh
media for varying time intervals. After removal of the
pegs, the amounts of bacteria that remained on the pegs
were quantified by crystal violet staining. Compared to
the controls, preformed A. baumannii and E. coli bio-
films treated with BS at 100 mg/ml for 1 hr did not pro-
duce any dispersion effect. However, when biofilms were
exposed for longer durations (~18 hrs), an increased bio-
film dispersion was observed (Figure 3). Furthermore, an
increase in dispersion was also observed for S. aureus
biofilms when exposed to the BS at concentrations of
50 mg/ml for 18 hrs respectively (Figure 3).Figure 2 The ability of biosurfactants from L. jensenii (BSLJ)
and L. rhamnosus (BSLR) in reducing biofilm formation in
A. baumannii, E. coli and S. aureus is indicated. BS was used at
50 mg/ml for A. baumannii, E. coli and at 25 mg/ml for S. aureus.
Treated cells were statistically different from controls. The results
represent the means plus SEM. Student’s paired t test was used to
determine the statistical significance of the treated versus untreated
conditions (*, P < 0.05).
Figure 3 The ability of biosurfactants from L. jensenii (BSLJ)
and L. rhamnosus (BSLR) in dispersing biofilm formation in
A. baumannii, E. coli and S. aureus is indicated. BS was used at
100 mg/ml for A. baumannii, E. coli and at 50 mg/ml for S. aureus.
Treated cells were statistically different from controls. The results
represent the means plus SEM. Student’s paired t test was used to
determine the statistical significance of the treated versus untreated
conditions (*, P < 0.05).
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Results from the cell-mediated cytotoxicity assay are
presented in Figure 4. Human A549 lung epithelial cells
were treated with BS from both Lactobacilli strains at
various concentrations (25, 50, 100 and 200 mg/ml) for
24 h. Cytotoxicity was determined by LDH release accord-
ing to the manufacturer’s instructions and the total cell
number assay (Figure 4). Concentrations of 25-100 mg/ml
showed no toxicity. Both BS showed very low toxicity
levels at 200 mg/ml (Figure 4).Figure 4 Toxicity testing of BS in mammalian cells. A549
lung epithelial cells were treated as indicated and viability was
measured with LDH assay at 24 hours by following manufacturer’s
direction. X-axis indicates the BS, positive (triton) and negative
(PBS) controls.Transmission electron microscopy
TEM was used to evaluate the ultra-structural morpho-
logical alterations exerted to A. baumannii and S. aureus
in the presence of BSLR. We chose A. baumannii 5075
and S. aureus UAMS-1 strains to represent a Gram ne-
gative and Gram positive pathogen for analysis. Untrea-
ted cells of the both A. baumannii and S. aureus showed
a normal cell shape with an intact structure of the cell
wall, inner membrane and outer membrane. The images
of the A. baumannii samples treated with L. rhamnosus
BS were markedly different to those of the untreated
cells. Several BSLR treated A. baumannii cells had their
membranes damaged at certain areas of the bacterial cell
with accumulation of dense substance (Figure 5). Sur-
prisingly we also found that L. rhamnosus BS seems to
cause more damage specifically to the ends of the bac-
terial cell (Figure 5). S. aureus cells treated with L. rham-
nosus BS exhibited profound structural differences when
compared to untreated cells. Several cells were observed
devoid of cell walls, a phenomenon called as “ghost”
cells. The dark and light areas observed in the cells were
indicative of high and low electron densities respectively.
Several cells were found to contain septa when com-
pared with the control samples (Figure 5). This may be
due to BS interfering with the cell division process and
this is probably indicative of one of the mechanisms of
action of BSLR by inhibiting the cell division.
Discussion
Here, we describe two cell-associated biosurfactants de-
rived from probiotic lactobacilli bacteria that possess
both antibacterial activities and inhibit biofilm formation
by several important drug-resistant pathogens. Although
some strains of lactobacilli are known to produce surfac-
tants, to the best of our knowledge there are no reports
on the abilities of L. jensenii and L. rhamnosus BS as anti-
biofilm agents. The crude BS derived from aforemen-
tioned bacteria showed significant antimicrobial activities
against A. baumannii, E. coli, MRSA and S. aureus at MIC
concentrations ranging between 25 and 50 mg/ml. L.
jensenii BS showed antimicrobial activity at 25 mg/ml
against all three pathogens with killing that varied from
75-99.9%, and at 12.5 mg/ml, it showed 90-100% killing
against MRSA. In addition, we observed similar anti-
microbial activities from both BS with similar MIC con-
centrations against MDR Klebsiella pneumoniae (Table 2).
In this study, we clearly showed the effect of BS on
the bacterial cells by transmission electron microscopy
(Figure 5). The bacterial cell membrane appears to be the
target of BS activity and subsequent microbicidal activity
of BS may be due to the leakage of cellular contents. BS
that exhibit antimicrobial activity has been previously
described [33-35], but to date there have been very few
studies on the activity of BS isolated from lactobacilli
A. 
S. aureus (High magnification) S. aureus + BSLR
+ BSLR
(High magnification) 
S. aureus (Low magnification) S. aureus + BSLR (Low magnification)
baumannii A. baumannii 
Figure 5 Transmission electron microscope details on A. baumanni and S. aureus treated with BSLR. A. baumannii and S. aureus grown in
the presence and absence of BSLR (4X MIC) were imaged at 3 h post incubation. Photographs were taken at a magnification of × 15000. The
thick arrow indicates septum formation and the thin arrow indicates the ghost cells appearance respectively. For S. aureus, images were also
acquired at lower magnification of ×8000, where a visible difference was seen between treated and untreated samples. BSLR treated S. aureus
showed many more ghost cells (thin arrows) and cells without visible intracellular organelles compared to untreated cells (thick double arrows).
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our studies were similar to the results from crude BS
studies on L. paracasei ssp. paracasei A20 and L. lactis,
which completely inhibited the growth of several micro-
organisms at concentrations ranging between 25 and
100 mg/ml [8,9,33]. In addition, BS exhibited excellent
anti-adhesive properties against S. aureus, A. baumannii
and E. coli, as evidenced in our adhesion based assays.
Next, the biofilm inhibition and dispersal capability of
BS against the above mentioned three pathogens wasevaluated. The crude BS isolated in this study exhibited
very good anti-biofilm activities against select microor-
ganisms. In the past, several studies have documented
the anti-biofilm activity of BS isolated from different
bacteria [19-21]. Preformed biofilms of all the three bac-
teria tested in microtiter plate wells were effectively dis-
rupted by the BS. The BS dispersed all three bacteria
when exposed for longer durations. The inhibition of
biofilms using surfactants has been reported previously
[12]. In addition, BS have been shown to disperse biofilms
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increased anti-biofilm and dispersal ability of the BS cur-
rently being investigated may be due to the two important
properties that it displays, namely, antimicrobial and sur-
factant activity. Previous studies with a BS isolated from
Lactobacillus spp. have only demonstrated its antimicro-
bial and anti-adhesive properties [33]. Here we report for
the first time BS isolated from lactobacillus also displaying
anti-biofilm properties. Both L. jensenii and L. rhamnosus
BS were able to significantly reduce biofilm development
by A. baumannii, E. coli and S. aureus.
The use and applications of BS in the medical field has
increased considerably in the last years. The impact of
BS in bacterial adhesion and desorption has been widely
discussed, and subsequent adsorption of these BS to so-
lid abiotic surfaces could prove an effective strategy to
reduce bacterial adhesion, thereby combating microbial
colonization in both medicine and industry [7,30,36,37].
The anti-biofilm and anti-adhesive activities of the BS
observed against several pathogens in our studies opens
up the possibility of using them to coat a variety of med-
ical surfaces to drastically reduce microbial colonization.
In conclusion, in this work we have demonstrated the
antimicrobial, anti-biofilm, and anti-adhesive properties of
the crude BS isolated from L. jensenii against several pa-
thogenic MDR bacteria. We also observed that addition of
both BS at effective concentrations to eukaryotic cells re-
sulted in low cytotoxicity (Figure 4), suggesting the safety
of these compounds for topical delivery. Biofilm en-
croachment on biomaterial is an extremely important
concern post-surgery. Hence, our results open the possi-
bility of using BS-modified materials for the construction
of biofilm-resistant medical implantable devices, given its
broad-spectrum activity against both Gram-positive and
Gram-negative bacterial strains. BS exhibits potential as a
new therapeutic strategy to inhibit biofilm formation. Be-
cause the increased prevalence of antibiotic-resistant bac-
teria generates a need for alternate and novel strategies to
combat biofilms, we believe that co-administering antibi-
otics with anti-biofilm agents that possess surface activ-
ities such as BS may form the basis of future clinical
protocols against biofilm-based infections.
Currently, experiments are underway to characterize the
crude fractions of the surfactants by high performance li-
quid chromatography. We have identified certain fractions
that exhibit excellent antimicrobial activities against A.
baumanni, S. aureus, K. pneumoniae and E. coli. These
fractions are being further analyzed by mass spectrometry
and Matrix assisted laser desorption/ionization- time of
flight (MALDI-TOF) to identify the active component/s.
Conclusion
The BS produced by L. jensenii and L. rhamnosus
showed antiadhesive, antimicrobial and antibiofilm activitiesagainst several MDR bacteria, such as E. coli, A. baumannii
and S. aureus, which are prominent biofilm formers on
wounds, medical implants and industrial surfaces. Anti-
adhesive and antimicrobial activities were seen between
25-100 mg/ml. MBEC based biofilm assays confirmed the
inhibitory action of BS on biofilm development at concen-
trations ranging 25-50 mg/ml. In addition, BS dispersed
preformed biofilms of A. baumannii and S. aureus at
concentrations ranging 50-100 mg/ml. Due to its sur-
face tension reduction properties, BS can be used to
coat medical surfaces to prevent microbial colonization by
variety of bacteria causing indwelling device associated
infections.
Methods
Strains and growth conditions
L. jensenii 25258 and L. rhamnosus 7469 were purchased
from ATCC (ATCC, Manassas, VA, USA). The strains
were stored at -80°C in MRS broth (Difco, Sparks, MD,
USA) containing 20% (v/v) glycerol. Multi-drug-resistant
test strains were stored at −80°C in the appropriate me-
dia with 15% (v/v) glycerol until use. E. coli strains EC433,
EC438, A. baumannii strains AB5075, AB5711 were
cultured in LB broth and S. aureus clinical isolate 243
(MRSA) and UAMS-1 in trypticase soy broth. All the
strains were grown at 37°C for 4 h in the appropriate
media, and were washed in PBS 2X and resuspended in
PBS to the appropriate OD at 600 nm for testing.
BS production and isolation
To isolate cell-associated BS, the following protocol was
pursued according to previously published methods used
by several other investigators for lactobacilli BS [8,10,33].
For crude BS production by L. jensenii 25258, 1200 ml of
MRS culture broth was inoculated with 10 ml of an over-
night culture of L. jensenii and incubated for 48 h at 37°C
at 120 RPM on a shaker. For L. rhamnosus, 1200 ml cul-
ture of MRS broth was inoculated with 10 ml of an over-
night culture and incubated for 48 h at 33°C without
shaking. After 48 hours, cell pellets were collected by
centrifugation (10000 × g, 10 min, 10°C), washed twice in
demineralized water, and re-suspended in 100 ml of PBS.
This solution was gently stirred at room temperature for
2 h to release the cell-bound BS. After 2 hours, bacteria
were removed by centrifugation and the supernatant li-
quid was collected by filtering through a 0.22 um filter.
The filtered sterile supernatant was lyophilized. The
freeze-dried BS was stored at -20°C, and resuspended in
deionized water at 100 mg/ml (w/vol).
Antimicrobial assay with BS
The antimicrobial activities of L. jensenii and L. rhamnosus
crude BS against several pathogens were determined in
96-well tissue culture plates by a modified microdilution
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MHB broth was placed into the first column of the 96-
well microplate and 100 μl of sterile, single-strength MHB
broth in the remaining wells. Subsequently, 100 μl of BS
solution in PBS (100 mg/ml) was added to the first col-
umn of the microplate and mixed with the medium; this
resulted in a BS concentration of 50 mg/ml, and 100 μl
was transferred serially to the subsequent wells, resulting
in two-fold dilutions. Columns without BS served as posi-
tive growth controls. All the wells were inoculated with
100 μl of 108 CFU from each of the test strains from a log
phase culture. Microtiter plates were covered and incu-
bated for 24 h under the appropriate growth conditions
for each microorganism. Three independent preparations
of crude BS were tested in duplicate. The contents of each
well were plated onto LB agar plates with appropriate dilu-
tions, and CFU were enumerated the next day. Percent
killing was calculated as 1- (treated/control × 100).
Oil spreading assay to determine surfactant activity
For the oil spreading assay, 50 ml of demineralized water
was added to a 150 mm diameter Petri dish and 20 μl of
motor oil was added to the surface of the water. Ten mi-
croliters of crude BS from either L. jensenii or L. rham-
nosus, dissolved in deionized water was then added to
the surface of the oil at concentrations ranging from
6.25 to 50 mg/ml. Surfactin was used as a positive con-
trol at the same concentrations, and a negative control
was included with PBS. The diameters of clear zones of
triplicate assays from the same sample were determined.
Cytotoxicity assay
The human lung epithelial cell line (A549) was used in
this study. The cytotoxicity of the crude BS from both
Lactobacilli was evaluated on eukaryotic cells by the re-
lease of lactate dehydrogenase (LDH) and total cell num-
ber assay. The LDH cytotoxicity assay was performed
according to the manufacturer’s guidelines (CytoTox 96
Non-Radioactive Cytotoxicity Assay, Promega, Madison,
WI, USA). After the addition of the crude BS at different
concentrations for 24 h, the cell culture medium was
collected for LDH measurement after lysis of cells. An
aliquot of 50 μl cell medium was used for LDH activity
analysis and the absorption was measured using a UV–
visible spectrophotometer. Percentage cytotoxicity was
calculated as the percentage of LDH released compared
to untreated cells. All experiments were repeated three
times, each in triplicate.
Assessment of biofilm formation
Biofilm formation was measured under two static condi-
tions using a quantitative crystal violet assay. BS was
added to the wells that contained the media and bac-
terial cells. BS were used at 25-50 mg/ml concentrationsin final total volume not exceeding 165 μl, the volume
at which the biofilms develop well in the MBEC bio-
film assay. Biofilms of A. baumannii were developed on
polystyrene 96-well and MBEC (Biosurface Technolo-
gies, Bozeman, MT, USA) as described previously by
Sambanthamoorthy, 2012 [38]. Briefly, cultures grown
overnight were standardized to an OD595 of 0.05 and
165 μl was transferred to the wells of a 96-well polystyr-
ene microtiter plate, and the MBEC lid was placed on
top of the wells. BS were added concurrently to the wells
and biofilms were grown on the pegs under shaking con-
ditions for 24 h. The lid was removed and the pegs were
gently washed twice with 200 μl of PBS to remove non-
adherent cells. Adherent biofilms on the pegs were fixed
with 200 μl of 100% ethanol prior to staining for 2 min
with 200 μl of 0.41% (wt/vol) crystal violet in 12% etha-
nol (Biochemical Sciences, Swedesboro, NJ, USA). The
pegs were washed several times with PBS to remove ex-
cess stain. Quantitative assessment of biofilm formation
was obtained by the immersion of pegs in a sterile poly-
styrene microtiter plate which contained 200 μl of 100%
ethanol and incubation at room temperature for 10 min
before the absorbance at 595 nm was determined. Three
independent experiments were performed for each of
these assays. Biofilms of S. aureus were developed on
polystyrene 96-well plates and evaluated against the BS
as previously described [39].
Biofilm dispersal
To determine if the BS could disperse preformed bio-
films, bacterial biofilms were established as previously
described [38,40]. Briefly, established biofilms were ex-
posed to varying concentrations of the BS in fresh media
for short time intervals. Adherent biofilms on the pegs
were fixed with 200 μl of 100% ethanol prior to staining
for 2 min with 200 μl of 0.41% (wt/vol) crystal violet
in 12% ethanol (Biochemical Sciences, Swedesboro, NJ,
USA). Quantitative assessment of biofilm formation was
obtained by the immersion of pegs in a sterile polystyr-
ene microtiter plate which contained 200 μl of 100%
ethanol; the absorbance at 595 nm was determined using
a SpectraMax M5 microplate spectrophotometer system.
Results were interpreted by the comparison of BS on
treated biofilms to untreated biofilms. Experiments were
performed in triplicate and three independent experi-
ments were performed for each of these assays.
Adherence of A. baumannii, E. coli and S. aureus to abiotic
surfaces
An initial adherence assay was used to measure the impact
of BS on the surface binding capacity of A. baumannii, E.
coli and S. aureus. The assay was performed by modifying
a microtiter biofilm assay as described previously [39].
Briefly, overnight cultures of A. baumannii and S. aureus
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at 595 nm in fresh medium, and 200 μl was added to
each well (polystyrene pre-coated with human plasma)
in triplicate. This was followed by adding BS at relevant
concentration to be tested into the wells. Following 1 h
incubation at 37°C, the microtiter wells were washed
three times with PBS. Adherent cells were then fixed with
200 μl of 100% ethanol for 10 min. The ethanol was re-
moved and the wells were air dried for 2 min. Adherent
cells were stained for 2 min with 200 μl of 0.41% crystal
violet (w/v in 12% ethanol), then washed three times with
PBS. The wells were allowed to dry and then eluted with
ethanol. Absorbance readings were made at 595 nm using
a SpectraMax M5 microplate spectrophotometer system
(Molecular Devices, Sunnyvale, CA, USA). Experiments
were performed in triplicate and three independent exper-
iments were performed for each of these assays.
Transmission electron microscopy
A log phase culture of A. baumannii and S. aureus
in separate tubes containing LB broth was split into
1.5 ml aliquots. The cells were collected by centrifuga-
tion (10000 × g, 5 min) and resuspended in PBS (Sigma-
Aldrich, St. Louis, MO, USA). Four samples were prepared;
two untreated, two treated with BSLR (4X MIC). The
samples were incubated at 37°C for 3 h. The cells were col-
lected by centrifugation (10000 × g, 5 min) to aspirate the
supernates. To fix the cells, 4% glutaraldehyde was added
to the pellet and the samples were incubated at 4°C for 1 h.
The cells were collected by centrifugation (10000 rpm,
5 min) and washed twice with 0.1 M phosphate buffer. To
postfix the cells, 1% osmium tetraoxide was added and the
samples were left at room temperature for 1 h. The sam-
ples were dehydrated with graded ethanol solutions (50%
ethanol for 15 min, 70% ethanol for 15 min, 95% ethanol
for 15 min, and 100% ethanol for 30 min), embedded in
epon and left to polymerize for 24 hrs. From each sample
10 thin slices (approximately 100 nm) were cut with Leica
ultra cut UCT (Leica, Buffalo grove, IL, USA). Each of
these sections was examined with a JEOL 1400 transmis-
sion electron microscope (JEOL, Peabody, MA, USA).
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